STAT

MARCH 29, 2024

For babies who are breastfed, their first source of sustenance is filled with proteins, sugars, hormones, vitamins, and minerals — just the right amount of nutrients for an infant. That milk could also lower the risk of asthma , diabetes, and allergies. And it could make low-birth-weight, preterm babies up to 10 times less likely to develop necrotizing enterocolitis , a common intestinal disorder.

Diabetes 361

Diabetes 361

PharmaVoice

MARCH 29, 2024

Rivus’ controlled metabolic accelerators are an emerging new potential competitor to popular weight loss and diabetes drugs from Novo Nordisk and Eli Lilly.

Diabetes 162

Diabetes 162

STAT

MARCH 29, 2024

Diabetes drugs are too expensive in the U.S., and insulin is infamously six to 13 times more expensive here than in comparable high-income countries. And blockbuster GLP-1 drugs, too, could be a lot less expensive, according to an investigation published this week in JAMA Network Open, with a simple change: robust generic competition. The study, led by Melissa Barber, a Yale postdoctoral fellow, and conducted in collaboration with Doctors Without Borders, a nonprofit medical organization working

Diabetes 335

Diabetes Drug Pricing 335

BioPharma Dive

MARCH 29, 2024

Confirmatory results for Krazati, which Bristol Myers acquired via its buyout of Mirati, could help the drug win full approval while Amgen has been set back.

114

114

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MARCH 29, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at key Supreme Court decision, the latest biotech IPO, and intrigue over Chinese outsourcing.

Drug Pricing 227

Drug Pricing Drug Development 227

Pharmaceutical Commerce

MARCH 29, 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses the specific factors contributing to rising manufacturing costs.

104

104

pharmaphorum

MARCH 29, 2024

Report claims US intelligence services advised the authors of the BIOSECURE Act that WuXi AppTec shared confidential data on US clients with the Chinese government

94

94

STAT

MARCH 29, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

200

200

PharmaTech

MARCH 29, 2024

FDA has approved AstraZeneca's Ultomiris, marking the first and only long-acting C5 complement inhibitor for patients with NMOSD.

98

98

pharmaphorum

MARCH 29, 2024

Bristol-Myers Squibb's Zeposia has failed to outperform placebo in its first phase 3 test in Crohn's disease

88

88

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Compounding Pharmacy of America

MARCH 29, 2024

An exploration of how proper diet, exercise, and a regiment of supplements combined with GLP-1 therapies can prevent and treat type 2 diabetes. The post The Role of GLP-1 Therapies in Type 2 Diabetes Prevention and Treatment appeared first on The Compounding Pharmacy of America.

Diabetes 59

Diabetes Compounding Pharmacies Compounding 59

Pharmaceutical Business Review

MARCH 29, 2024

This sNDA extends the indication of Vemlidy, a once a day 25mg tablet for usage in children aged six years and above weighing a minimum of 25kg with compensated liver disease. Vemlidy, a targeted prodrug of tenofovir, was initially approved by the US regulator in 2016 for adults with chronic HBV infection and compensated liver disease. The recent approval builds on a 2022 decision which allowed its use in paediatric patients aged 12 years and above.

Labelling 59

Labelling 59

FDA Law Blog: Biosimilars

MARCH 29, 2024

By John W.M. Claud & Kalie E. Richardson — While Covid is in the rear view for most of us, FDA has had a tough time shaking off the effects of the pandemic on its inspection output. Inspections went down—way down—during the pandemic. In March 2020 , FDA temporarily postponed all foreign and domestic and routine surveillance facility inspections.

Hospitals 59

Hospitals 59

Drug Patent Watch

MARCH 29, 2024

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.

59

59

Pharmaceutical Commerce

MARCH 29, 2024

The latest news for pharma industry insiders.

105

105

Pharmaceutical Technology

MARCH 29, 2024

Discover how Arvinas Inc's newly granted patent for compounds treating prostate cancer could revolutionize healthcare. Learn more about the potential for new drugs and therapies.

Compounding 52

Compounding 52

pharmaphorum

MARCH 29, 2024

Explore the key aspects of clinical trial supply management, including insights on Clinigen and its role in supporting clinical research trials. Learn how this backbone of breakthroughs can drive success in clinical trials.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Discover the groundbreaking patent by Yield10 Bioscience Inc for a genetically engineered oilseed plant expressing a plant protein, revolutionizing biotechnology in agriculture.

52

52

Pharmaceutical Commerce

MARCH 29, 2024

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the hottest therapeutic settings for dealmaking activity at the moment—and one platform approach in particular poised to be at the center of future M&A and licensing pursuits.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Discover the innovative dermal patch system by Sun Pharmaceutical Industries Ltd for efficient and minimally invasive physiological sample collection. Patent US11877848B2 revolutionizes sample processing with a unique design.

52

52

PharmExec

MARCH 29, 2024

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Discover how Crinetics Pharmaceuticals Inc's patent for compounds modulating somatostatin activity can suppress hormone secretion in mammals. Explore the detailed framework for hormone modulation and SSTR2 activity regulation.

Compounding 52

Compounding 52

Pharma and Life Sciences Blog

MARCH 29, 2024

A Leading Fast-Food Chain Saves Millions on Direct Material Category With GEP annmarie@AZglo… Fri, 03/29/2024 - 13:13 A global fast-food chain sought to align the supplier base for its $545 million pork category with its corporate animal welfare goals and consolidate spend with key suppliers. The company looked to GEP to help drive this strategic realignment.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Expand transplantable NK cell fractions for cancer treatment with Gamida Cell's patented method. Culturing, supplementing, and storing cells ensure improved outcomes for cancer patients.

52

52

Drug Patent Watch

MARCH 29, 2024

Annual Drug Patent Expirations for PREVDUO Prevduo is a drug marketed by Slayback Pharma Llc and is included in one NDA. It is available from one supplier.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Discover Rohto Pharmaceutical's patented ophthalmic composition with crocetin and ginkgo leaf extract, proven to prevent and treat myopia in all ages. Explore the groundbreaking method for treating axial myopia and ocular diseases.

52

52

Drug Patent Watch

MARCH 29, 2024

Annual Drug Patent Expirations for ZEPBOUND Zepbound is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Revolutionize your labeling process with Angelini Spa's patented method using a robot and label printer to efficiently attach printed labels to reels. Patent Publication Number: US11884443B2.

Labelling 52

Labelling 52

PharmaTech

MARCH 29, 2024

Can Cellares deliver on the goal to meet total patient demand for cell therapies globally? CEO Fabian Gerlinghaus discusses.

59

59

Pharmaceutical Technology

MARCH 29, 2024

Discover the innovative injectable composition of testosterone undecanoate by Chong Kun Dang Pharmaceutical Corporation. Patented for treating testosterone deficiency, this composition offers enhanced stability and ease of use during injection.

52

52

Drug Patent Watch

MARCH 29, 2024

Annual Drug Patent Expirations for VELTASSA Veltassa is a drug marketed by Vifor Pharma and is included in one NDA. It is available from one supplier.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Discover how CSL Ltd's patented method using alpha-1 antitrypsin (A1AT) can reduce the risk of graft versus host disease in hematopoietic cell transplantation patients. Published as US11857610B2, this groundbreaking approach offers hope for improved outcomes.

52

52

Drug Patent Watch

MARCH 29, 2024

Annual Drug Patent Expirations for XOFLUZA Xofluza is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier.

52

52

Pharmaceutical Commerce

MARCH 29, 2024

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Drug Pricing 52

Drug Pricing 52

Drug Patent Watch

MARCH 29, 2024

Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier.

52

52